Last updated on October 26, 2025
Yes. Brazil allows the use of genetically modified mosquitoes for dengue control. The National Technical Commission on Biosafety (CTNBio) approved their commercial release after a full biosafety evaluation under federal law.
When Science Takes Flight
In the tropical heat of Campinas, São Paulo, a quiet revolution buzzes through the air—literally. Swarms of male mosquitoes, bred in labs and genetically modified to sabotage their own species, are being released into the wild. Their mission? To help Brazil win its long-standing war against dengue.
This isn’t science fiction. It’s a government-approved public health strategy. And it’s happening under the watchful eye of Brazil’s top biosafety authority.
The Legal Wings Behind the Buzz
Brazil’s legal framework for genetically modified organisms (GMOs) is one of the most comprehensive in Latin America. The cornerstone is Law No. 11.105/2005, which established the National Biosafety Technical Commission—CTNBio. This body is responsible for evaluating the safety of GMOs for human health, agriculture, and the environment.
In 2020, CTNBio approved the commercial release of a genetically modified strain of Aedes aegypti mosquitoes, known as OX5034. Developed by Oxitec do Brasil Ltda., these male mosquitoes carry a self-limiting gene that causes female offspring to die before reaching maturity. Since only female mosquitoes bite and transmit diseases like dengue, Zika, and chikungunya, this genetic trick aims to collapse local mosquito populations over time.
The approval wasn’t handed out lightly. CTNBio conducted a thorough biosafety assessment, concluding that the OX5034 strain met all legal and technical requirements. The decision was based on scientific evidence, environmental risk assessments, and compliance with national biosafety regulations.
How It Works
The OX5034 mosquitoes are engineered with a gene that is lethal to females. When released into the wild, these males mate with wild females. The resulting female larvae inherit the gene and die before adulthood, while male offspring survive and continue the cycle. Over time, this reduces the number of disease-spreading females in the population.
Importantly, only male mosquitoes are released. They don’t bite, don’t transmit disease, and are designed to disappear from the environment after a few generations. This makes the method both targeted and temporary—two key factors in its regulatory approval.
Public Health Meets Public Policy
Brazil’s decision to greenlight genetically modified mosquitoes reflects a broader shift toward innovation in public health. Traditional methods—like insecticides and habitat control—have struggled to keep up with the rapid spread of arboviruses. The GM mosquito strategy offers a complementary tool, especially in urban areas where mosquito breeding sites are hard to eliminate.
The Ministry of Health has supported pilot programs in several cities, integrating the technology into broader dengue control plans. These efforts are part of a national strategy to reduce the burden of mosquito-borne diseases, which affect millions of Brazilians each year.
Transparency and Oversight
CTNBio’s approval process includes public consultation, technical documentation, and post-release monitoring. The agency also coordinates with other federal bodies to ensure that the technology is used responsibly and transparently. This includes environmental monitoring and community engagement to address public concerns.
Brazil’s approach balances innovation with caution. By embedding genetic mosquito control within a strong legal and scientific framework, the country is setting a precedent for how emerging biotechnologies can be safely deployed in public health.
See more on BRAZIL
Sources
Lei n. 11.105 de 24/03/2005 – CTNBio
http://ctnbio.mctic.gov.br/en/leis/-/asset_publisher/NT53w3Yb7zpx/content/lei-n-11-105-de-24-03-2005
Ongoing
Parecer Técnico 6946/2020 – CTNBio
http://ctnbio.mctic.gov.br/documents/566529/2318901/Parecer+T%C3%A9cnico+6946_2020/b8cb3aa0-26af-42a8-bedd-d081e042f3f7
2020-05-21